NCT00497731View on ClinicalTrials.gov

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

PHASE1TerminatedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

April 30, 2009

Conditions

Solid Tumors

Interventions

DRUG

AZD1152

2-hour continuous intravenous infusion

Trial Locations (2)

Unknown

Research Site, Amsterdam

Research Site, Utrecht

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY